Watchlist Price Alert

China Traditional Chinese... (CHIZF)

PNK: CHIZF · Real-Time Price · USD

0.34

0.00 (1.19%)

At close: May 05, 2025, 8:00 PM

China Traditional Chinese Medicine Income Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Jun 30, 2018	Dec 31, 2017	Jun 30, 2017	Dec 31, 2016	Jun 30, 2016
Revenue	17.2B	18.12B	17.7B	14.3B	16.82B	19.05B	16.3B	14.81B	14.04B	14.32B	12.73B	11.26B	9.9B	8.34B	7.23B	6.53B	5.49B
Cost of Revenue	8.63B	8.85B	8.69B	7.11B	7.04B	7.22B	6.19B	5.68B	5.63B	5.75B	5.28B	5.07B	4.49B	3.69B	3.11B	2.75B	2.31B
Gross Profit	8.58B	9.27B	9B	7.2B	9.78B	11.83B	10.11B	9.13B	8.41B	8.58B	7.45B	6.19B	5.41B	4.65B	4.12B	3.79B	3.18B
Operating Income	997.81M	1.4B	1.42B	1.17B	1.95B	2.71B	2.69B	2.47B	2.28B	2.43B	2.24B	2.1B	1.97B	1.76B	1.49B	1.29B	1.01B
Interest Income	59.65M	133.79M	156M	153.43M	145.45M	159.45M	191.8M	197.07M	254.7M	163.86M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	817.15M	1.22B	1.08B	840.11M	1.79B	2.52B	2.44B	2.23B	2B	2.15B	1.99B	1.86B	1.77B	1.57B	1.44B	1.3B	1.06B
Net Income	917.44M	1.29B	929.64M	764.49M	1.42B	1.93B	1.86B	1.66B	1.46B	1.59B	1.54B	1.44B	1.33B	1.17B	1.07B	966.93M	793.53M
Selling & General & Admin	7.18B	7.46B	7.1B	5.56B	7.26B	8.57B	6.99B	6.33B	5.81B	5.81B	4.97B	3.88B	3.3B	2.77B	2.42B	2.3B	2B
Research & Development	639.94M	685.63M	607.91M	611.83M	717.27M	694.44M	599.85M	550.47M	500.32M	464M	406.45M	346.54M	229.65M	202.16M	208.4M	186.83M	180.79M
Other Expenses	-239.83M	-226.95M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-31.43M	-62.85M	-64.87M	-66.89M
Operating Expenses	7.58B	7.88B	7.77B	6.2B	7.84B	9.15B	7.48B	6.7B	6.15B	6.17B	5.22B	4.09B	3.42B	2.9B	2.58B	2.43B	2.13B
Interest Expense	n/a	238.49M	512.57M	274.08M	n/a	n/a	n/a	n/a	n/a	150.52M	301.05M	296.67M	292.3M	256.68M	221.07M	147.25M	73.42M
Selling & Marketing Expenses	5.97B	6.4B	6.07B	4.6B	6.26B	7.58B	6.19B	5.59B	5.1B	5.11B	4.38B	3.42B	2.9B	2.44B	2.11B	1.97B	1.63B
Cost & Expenses	16.21B	16.73B	16.46B	13.31B	14.88B	16.37B	13.67B	12.38B	11.78B	11.92B	10.51B	9.15B	7.91B	6.58B	5.68B	5.17B	4.44B
Income Tax Expense	346.68M	351.24M	160.76M	119.14M	253.84M	396.86M	400.52M	369.45M	355.47M	381.32M	307.27M	289.67M	287.76M	255.8M	233.47M	217.26M	192.4M
Shares Outstanding (Basic)	5.04B	5.04B	5.04B	5.04B	5.04B	5.04B	5.04B	5.04B	5.04B	5.04B	5.04B	5.04B	4.61B	4.43B	4.43B	4.43B	4.47B
Shares Outstanding (Diluted)	5.04B	5.04B	5.04B	5.04B	5.04B	5.04B	5.04B	5.04B	5.04B	5.04B	5.04B	5.04B	4.61B	4.43B	4.43B	4.43B	4.47B
EPS (Basic)	0.18	0.26	0.18	0.15	0.28	0.38	0.37	0.33	0.29	0.32	0.31	0.30	0.29	0.26	0.24	0.22	0.18
EPS (Diluted)	0.18	0.26	0.18	0.15	0.28	0.38	0.37	0.33	0.29	0.32	0.31	0.30	0.29	0.26	0.24	0.22	0.18
EBITDA	2B	2.42B	2.48B	2.22B	2.9B	3.5B	3.4B	3.11B	2.86B	2.98B	2.79B	2.61B	2.44B	2.16B	1.83B	1.61B	1.28B
EBIT	936.42M	1.35B	1.42B	1.17B	1.95B	2.71B	2.69B	2.47B	2.28B	2.43B	2.24B	2.1B	1.97B	1.76B	1.49B	1.29B	1.01B
Depreciation & Amortization	1.07B	1.07B	1.07B	1.04B	948.35M	795.72M	707.04M	641.13M	572.97M	547.67M	541M	505.63M	465.4M	402.31M	340.1M	326.2M	265.72M